Patient3i Partners and Collaborators
A Global Patient Dialogue is delivered by Patient3i who brings together trusted Partners and Collaborators
Partners
Patient3i provides the platform for the series, handling all logistics for the meeting with specific policies and procedures to ensure high quality and transparency; coordinates with partners to ensure delivery excellence.
Patient advocacy organizations — specific to the disease of interest — provide key content expertise and individual representative patient experts and manages patients’ expectations.
National Health Council, a key collaborator in the US guides the process by providing standards for patient engagement, training, representativeness, primary contact with FDA, and will bridge global standards and methods with multiple stakeholders.
EU partners and collaborators will mirror the US consortium approach for a planned Global Patient Dialogue in the US: all stakeholders, participants and patient organizations will benefit from a global perspective for the disease condition.
Health Care Innovators/participants register for the meeting, attend, engage with patients and receive the Global Patient Dialogue Report for both US and EU Global Patient Dialogues.
What You’ll Experience
“One of the 21st Century pioneers of patient engagement practice in the Life Science Industry, Patient 3i leadership has done much to shape the environmental context and establish best practice in an actionable, impactful and sustainable way.”
"Bridging the chasm between patients’ needs and priorities and healthcare delivery is essential to ensuring effective, affordable products and services. Listening to and understanding patients’ experiences and challenges is the engine for developing new, viable healthcare solutions."
"Patient partnership in drug development is an absolute necessity, but the time and space necessary for meaningful collaboration is not a luxury many patients or other stakeholders have. Patient3i provides the forum for patient-centered, multi-stakeholder collaboration in the development of life-saving and quality of life-preserving therapies."
"Our ideals change as we expand our experiences. Our world becomes larger and more fascinating, and we find the courage to act on those new ideals. This is what Patient 3i will do for innovation!"
"Global Patient Dialogues creates a convenient, compliant listening forum for global innovators and patient communities to learn from each other directly!"
“Researchers and Innovators in Health Care will embrace a coordinated, efficient and trusted model driven by Patient Organization leadership, which defines relevant value for patients, informed by the latest regulatory guidance and patient engagement standards.”